{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Picotamide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Picotamide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Picotamide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "picotamide",
    "trial_2_text": "Picotamide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Picotamide Supplement: 60 participants will take Picotamide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Picotamide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Picotamide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2690016031265259,
      "78": 0.25044363737106323,
      "37": 0.15743310749530792,
      "123": 0.15581849217414856,
      "17": 0.15534962713718414,
      "177": 0.15368011593818665,
      "20": 0.14581671357154846,
      "46": 0.14314056932926178,
      "173": 0.14117072522640228,
      "68": 0.13588768243789673,
      "21": 0.1352696716785431,
      "189": 0.12628044188022614,
      "9": 0.12511341273784637,
      "14": 0.12260794639587402,
      "67": 0.12026949971914291,
      "49": 0.11569447070360184,
      "79": 0.11157447099685669,
      "188": 0.10469800978899002,
      "77": 0.10242120176553726,
      "228": 0.10212447494268417,
      "200": 0.10105619579553604,
      "2": 0.0997563973069191,
      "114": 0.09865354746580124,
      "350": 0.09255451709032059,
      "64": 0.08587435632944107,
      "5": 0.08360318094491959,
      "72": 0.08142023533582687,
      "104": 0.08141715079545975,
      "85": 0.0781744122505188,
      "193": 0.0778878778219223,
      "126": 0.07612791657447815,
      "101": 0.0756397694349289,
      "29": 0.07394461333751678,
      "76": 0.0731365755200386,
      "180": 0.07263138890266418,
      "27": 0.07153724133968353,
      "243": 0.06990963220596313,
      "239": 0.0695076584815979,
      "86": 0.06865479797124863,
      "28": 0.06854154169559479,
      "18": 0.06182287260890007,
      "116": 0.061292532831430435,
      "131": 0.06092353165149689,
      "139": 0.05995950475335121,
      "276": 0.058865614235401154,
      "194": 0.05816919356584549,
      "61": 0.0576336532831192,
      "147": 0.05721946060657501,
      "179": 0.05669192597270012,
      "144": 0.056446414440870285,
      "122": 0.05633952468633652,
      "30": 0.05607860907912254,
      "396": 0.05461544916033745,
      "82": 0.05422496423125267,
      "151": 0.05367600545287132,
      "69": 0.05340356007218361,
      "102": 0.05326506868004799,
      "269": 0.04987762123346329,
      "253": 0.048933837562799454,
      "1": 0.04866739735007286,
      "92": 0.048289768397808075,
      "204": 0.04804791510105133,
      "38": 0.047920551151037216,
      "234": 0.047816287726163864,
      "355": 0.047804031521081924,
      "282": 0.047074466943740845,
      "100": 0.04686086252331734,
      "261": 0.046677183359861374,
      "191": 0.0462995208799839,
      "164": 0.04603447765111923,
      "441": 0.04347841441631317,
      "75": 0.04299542307853699,
      "130": 0.04240591078996658,
      "339": 0.04236791655421257,
      "33": 0.04229141026735306,
      "97": 0.041959524154663086,
      "96": 0.04171881452202797,
      "466": 0.04128766804933548,
      "4": 0.040863286703825,
      "35": 0.04014511778950691,
      "186": 0.03957221284508705,
      "341": 0.039307188242673874,
      "288": 0.03901342675089836,
      "212": 0.038690127432346344,
      "257": 0.03867446258664131,
      "508": 0.03835219889879227,
      "249": 0.037802767008543015,
      "400": 0.037736281752586365,
      "153": 0.03740350157022476,
      "142": 0.03722560033202171,
      "163": 0.037048690021038055,
      "221": 0.03698742762207985,
      "382": 0.036844201385974884,
      "286": 0.036746326833963394,
      "132": 0.03625194728374481,
      "262": 0.036134280264377594,
      "454": 0.03541494905948639,
      "31": 0.034984927624464035,
      "11": 0.03470216691493988,
      "98": 0.033766455948352814
    },
    "trial_2_ae": {
      "87": 0.2690016031265259,
      "78": 0.25044363737106323,
      "37": 0.15743310749530792,
      "123": 0.15581849217414856,
      "17": 0.15534962713718414,
      "177": 0.15368011593818665,
      "20": 0.14581671357154846,
      "46": 0.14314056932926178,
      "173": 0.14117072522640228,
      "68": 0.13588768243789673,
      "21": 0.1352696716785431,
      "189": 0.12628044188022614,
      "9": 0.12511341273784637,
      "14": 0.12260794639587402,
      "67": 0.12026949971914291,
      "49": 0.11569447070360184,
      "79": 0.11157447099685669,
      "188": 0.10469800978899002,
      "77": 0.10242120176553726,
      "228": 0.10212447494268417,
      "200": 0.10105619579553604,
      "2": 0.0997563973069191,
      "114": 0.09865354746580124,
      "350": 0.09255451709032059,
      "64": 0.08587435632944107,
      "5": 0.08360318094491959,
      "72": 0.08142023533582687,
      "104": 0.08141715079545975,
      "85": 0.0781744122505188,
      "193": 0.0778878778219223,
      "126": 0.07612791657447815,
      "101": 0.0756397694349289,
      "29": 0.07394461333751678,
      "76": 0.0731365755200386,
      "180": 0.07263138890266418,
      "27": 0.07153724133968353,
      "243": 0.06990963220596313,
      "239": 0.0695076584815979,
      "86": 0.06865479797124863,
      "28": 0.06854154169559479,
      "18": 0.06182287260890007,
      "116": 0.061292532831430435,
      "131": 0.06092353165149689,
      "139": 0.05995950475335121,
      "276": 0.058865614235401154,
      "194": 0.05816919356584549,
      "61": 0.0576336532831192,
      "147": 0.05721946060657501,
      "179": 0.05669192597270012,
      "144": 0.056446414440870285,
      "122": 0.05633952468633652,
      "30": 0.05607860907912254,
      "396": 0.05461544916033745,
      "82": 0.05422496423125267,
      "151": 0.05367600545287132,
      "69": 0.05340356007218361,
      "102": 0.05326506868004799,
      "269": 0.04987762123346329,
      "253": 0.048933837562799454,
      "1": 0.04866739735007286,
      "92": 0.048289768397808075,
      "204": 0.04804791510105133,
      "38": 0.047920551151037216,
      "234": 0.047816287726163864,
      "355": 0.047804031521081924,
      "282": 0.047074466943740845,
      "100": 0.04686086252331734,
      "261": 0.046677183359861374,
      "191": 0.0462995208799839,
      "164": 0.04603447765111923,
      "441": 0.04347841441631317,
      "75": 0.04299542307853699,
      "130": 0.04240591078996658,
      "339": 0.04236791655421257,
      "33": 0.04229141026735306,
      "97": 0.041959524154663086,
      "96": 0.04171881452202797,
      "466": 0.04128766804933548,
      "4": 0.040863286703825,
      "35": 0.04014511778950691,
      "186": 0.03957221284508705,
      "341": 0.039307188242673874,
      "288": 0.03901342675089836,
      "212": 0.038690127432346344,
      "257": 0.03867446258664131,
      "508": 0.03835219889879227,
      "249": 0.037802767008543015,
      "400": 0.037736281752586365,
      "153": 0.03740350157022476,
      "142": 0.03722560033202171,
      "163": 0.037048690021038055,
      "221": 0.03698742762207985,
      "382": 0.036844201385974884,
      "286": 0.036746326833963394,
      "132": 0.03625194728374481,
      "262": 0.036134280264377594,
      "454": 0.03541494905948639,
      "31": 0.034984927624464035,
      "11": 0.03470216691493988,
      "98": 0.033766455948352814
    }
  },
  "safety": {
    "trial_1_safety": 0.34455811977386475,
    "trial_2_safety": 0.34455811977386475
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4797741770744324
  }
}